The Role of Adding Concurrent Chemotherapy to IMRT in the Treatment of Stage II Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
The study is designed to compare Intensity Modulated Radiotherapy (IMRT) in combination with
concurrent chemotherapy and IMRT alone in treatment of stage II nasopharyngeal carcinoma.